CLEARMIND MEDICINE, INC

Lobbying client · British Columbia · filed 2025 to 2026

Developer of Psychedelics Medicines

$80,000 Reported spend

7 Filings counted

1 Outside firm hired

6 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (67871), filed by the registrant listed below.

Who filed for this client 1

RK STRATEGIES, INC. $80,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 6

H.R. 2623
Innovative Therapies Centers of Excellence Act of 2025

5 filings
H.R. 7091
Expanding Veterans’ Access to Emerging Treatments Act

4 filings
H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…

2 filings
H.R. 8800
National Defense Authorization Act for Fiscal Year 2027

2 filings
H.R. 9237
Take Care of America’s Veterans Act

2 filings
H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

2 filings

Reported by year 2 years

2026 $50,000 3 filings
2025 $30,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 7 total

Q3 report

RK STRATEGIES, INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026

View → Q2 report

RK STRATEGIES, INC.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 18, 2026

View → Q1 report

RK STRATEGIES, INC.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $10,000 income · posted Apr 20, 2026

View → Q4 report

RK STRATEGIES, INC.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 income · posted Jan 20, 2026

View → Q3 report

RK STRATEGIES, INC.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2025

View → Q2 report

RK STRATEGIES, INC.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 21, 2025

View → Registration

RK STRATEGIES, INC.

2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 16, 2025

View →

Foreign entities disclosed 1

CLEARMIND MEDICINE, INC. Israel named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $10,000

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.